CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND VINCRISTINE (CAV) FOR RELAPSE IN SMALL-CELL LUNG-CANCER (SCLC) IN PATIENTS TREATED INITIALLY WITH VP-16 AND CISPLATIN (VPP)

被引：0
|
作者：
MACCORMICK, R [1 ]
SHEPHERD, FA [1 ]
EVANS, WK [1 ]
FELD, R [1 ]
YAU, J [1 ]
机构：
[1] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1986年 / 9卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [21] CISPLATIN AND ETOPOSIDE ALTERNATING WITH VINCRISTINE, DOXORUBICIN AND CYCLOPHOSPHAMIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    LITTLEWOOD, TJ
    SMITH, AP
    ANDERSON, G
    CHAPPELL, AG
    JAMES, KW
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1985, 67 (04): : 294 - 300
  • [22] ETOPOSIDE (VP-16) AND CISPLATIN IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER - CLINICAL-TRIAL AND INVITRO CORRELATES
    BATIST, G
    CARNEY, DN
    COWAN, KH
    VEACH, SR
    GILLIOM, M
    BUNN, PA
    IHDE, DC
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) : 982 - 986
  • [23] VP-16 AND CIS-PLATINUM (P) COMBINATION CHEMOTHERAPY FOR RELAPSE IN SMALL CELL LUNG-CANCER (SCLC)
    OSOBA, D
    EVANS, WK
    FELD, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 495 - 495
  • [24] CIS-PLATINUM(DDP),VP-16(VP),ADRIAMYCIN(ADM) COMBINATION FOR INDUCTION IN SMALL CELL LUNG-CANCER (SCLC) CHEMOTHERAPY
    DEMARINIS, F
    MACCONE, C
    CARMINATI, F
    POMPILI, T
    PALLOTTA, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 46 - 46
  • [25] PHASE-II STUDY OF VP-16 AND CARBOPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC)
    EVANS, W
    EISENHAUER, E
    HUGHES, P
    SHEPHERD, F
    FELD, R
    AYOUB, J
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : B109 - B109
  • [26] VP-16 AND CISPLATIN IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER
    KLASTERSKY, J
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 17 - 20
  • [27] VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE (VP16-213) IN SMALL-CELL ANAPLASTIC CARCINOMA OF THE LUNG
    VONEYBEN, FE
    ARWIDI, A
    HELLEKANT, C
    JONSSON, K
    LINDAHL, SA
    MATTSSON, W
    TENNVALL, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 195 - 197
  • [28] CARBOPLATIN, EPIRUBICIN, AND VP-16 CHEMOTHERAPY IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    GRIDELLI, C
    IANNIELLO, GP
    MAIORINO, A
    CURCIO, C
    DAPRILE, M
    BRANCACCIO, L
    PALMERI, S
    GENTILE, M
    COMELLA, G
    PEDICINI, T
    AIROMA, G
    VELTRI, E
    GEBBIA, V
    RUSSO, A
    CASARETTI, R
    GIAMPAGLIA, F
    FERRANTE, G
    RAUSA, L
    IACOBELLI, S
    ARCANGELI, G
    DEPLACIDO, S
    BIANCO, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 160 - 167
  • [29] A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE (CAV) WITH CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE, METHOTREXATE (CEVM) IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    ERKISI, M
    UNSAL, M
    TUNALI, C
    BURGUT, R
    DORAN, F
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (01) : 56 - 59
  • [30] HIGH-DOSE ETOPOSIDE (VP-16) IN SMALL-CELL LUNG-CANCER
    GRECO, FA
    JOHNSON, DH
    HANDE, KR
    PORTER, LL
    HAINSWORTH, JD
    WOLFF, SN
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 42 - 44
12345